Jump Financial’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.64M | Buy |
289,341
+100,743
| +53% | +$919K | 0.03% | 619 |
|
|
2025
Q1 | $1.5M | Buy |
+188,598
| New | +$1.5M | 0.02% | 673 |
|
|
2024
Q4 | – | Sell |
-17,802
| Closed | -$129K | – | 1953 |
|
|
2024
Q3 | $129K | Buy |
17,802
+4,267
| +32% | +$30.8K | ﹤0.01% | 1507 |
|
|
2024
Q2 | $147K | Sell |
13,535
-16,387
| -55% | -$178K | ﹤0.01% | 1601 |
|
|
2024
Q1 | $561K | Buy |
29,922
+8,504
| +40% | +$159K | 0.02% | 1116 |
|
|
2023
Q4 | $464K | Sell |
21,418
-66,883
| -76% | -$1.45M | 0.01% | 1109 |
|
|
2023
Q3 | $1.82M | Buy |
+88,301
| New | +$1.82M | 0.07% | 406 |
|
|
2022
Q3 | – | Sell |
-6,745
| Closed | -$218K | – | 1916 |
|
|
2022
Q2 | $218K | Buy |
+6,745
| New | +$218K | 0.01% | 1252 |
|
|
2021
Q3 | – | Sell |
-3,800
| Closed | -$216K | – | 1453 |
|
|
2021
Q2 | $216K | Buy |
+3,800
| New | +$216K | 0.02% | 822 |
|